In a new multi-institutional study, researchers have reported the devising of a new vaccination strategy using modified SARS-CoV-2 virus spike that promotes the production of antibodies that can block multiple coronaviruses.
How Do Lethal COVID-19 Variants Escape Immune System? Key Responsible Structural Changes In Virus Revealed [Study]
Scientists from Scripps Research Institute reveal that structural changes in a specific area of the spike protein due to mutations in SARS-CoV-2 coronavirus variants helps them evade immune responses of the body
Indian strain of COVID spread to 44 countries already: WHO
The world has been battling COVID-19 for nearly 18 months now. As the pandemic has progressed, the SARS-CoV-2 coronavirus has also mobilized new troops variants of concern (VOC). These evolved forms of the virus carry mutations that escape immune responses induced naturally or through vaccination. Now, a new study reveals the key mutation-led structural changes in the variants that enable them to evade the immune system.
Baku, May 16, AZERTAC
China s drug authority has granted emergency use approval to a COVID-19 vaccine developed by Shenzhen Kangtai Biological Products, the company said on Friday, according to CGTN.
In a statement, Kangtai said it is currently conducting Phase III trials for the inactivated vaccine.
It is the sixth approved vaccine after two from Sinopharm, one from Sinovac, one from CanSino and one from the Institute of Microbiology of the Chinese Academy of Sciences (IMCAS).
Kangtai has also obtained the exclusive right to develop and manufacture the vaccine developed by AstraZeneca and Oxford University on the Chinese mainland.
AZERTAG.AZ :Kangtai Biological s COVID-19 vaccine gets emergency use approval in China